Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Stoke Therapeutics, Inc. (STOK) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Stoke Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1623526.
Total stock buying since 2019: $94,976,446.
Total stock sales since 2019: $100,074,940.
Total stock option exercises since 2019: $1,617,262.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 194,400 | $3,028,554 | 152,995 | $70,699 |
| 2024 | 0 | $0 | 5,713,822 | $70,990,818 | 296,897 | $111,508 |
| 2023 | 0 | $0 | 114,740 | $1,211,057 | 20,000 | $12,000 |
| 2022 | 0 | $0 | 3,800 | $88,593 | 29,960 | $67,318 |
| 2021 | 0 | $0 | 141,368 | $6,183,333 | 98,170 | $253,894 |
| 2020 | 750,000 | $29,250,000 | 447,183 | $18,100,946 | 593,302 | $1,068,243 |
| 2019 | 3,538,550 | $65,726,446 | 16,434 | $471,639 | 56,000 | $33,600 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-09 | 0 | $0 | 87,624 | $1,762,261 | 9,150 | $64,690 |
| 2025-08 | 0 | $0 | 36,709 | $603,987 | 43,100 | $6,009 |
| 2025-07 | 0 | $0 | 4,503 | $52,378 | 0 | $0 |
| 2025-06 | 0 | $0 | 8,216 | $82,341 | 1,210 | $0 |
| 2025-05 | 0 | $0 | 26,631 | $266,948 | 0 | $0 |
| 2025-03 | 0 | $0 | 30,717 | $260,639 | 99,535 | $0 |
| 2024-12 | 0 | $0 | 62,849 | $805,678 | 122,883 | $6,000 |
| 2024-11 | 0 | $0 | 10,000 | $126,800 | 10,000 | $6,000 |
| 2024-10 | 0 | $0 | 10,000 | $120,650 | 10,000 | $6,000 |
| 2024-09 | 0 | $0 | 1,947,500 | $27,373,505 | 10,000 | $6,000 |
| 2024-08 | 0 | $0 | 10,000 | $145,840 | 10,000 | $6,000 |
| 2024-07 | 0 | $0 | 12,500 | $171,212 | 10,000 | $6,000 |
| 2024-06 | 0 | $0 | 10,000 | $154,960 | 10,000 | $6,000 |
| 2024-04 | 0 | $0 | 3,600,000 | $41,760,000 | 0 | $0 |
| 2024-03 | 0 | $0 | 30,973 | $226,833 | 82,275 | $0 |
| 2024-02 | 0 | $0 | 10,000 | $47,990 | 31,739 | $69,508 |
| 2024-01 | 0 | $0 | 10,000 | $57,350 | 0 | $0 |
| 2023-07 | 0 | $0 | 15,000 | $158,970 | 0 | $0 |
| 2023-06 | 0 | $0 | 24,740 | $298,230 | 0 | $0 |
| 2023-05 | 0 | $0 | 55,830 | $561,812 | 0 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 20,000 | $12,000 |
| 2023-02 | 0 | $0 | 18,970 | $190,045 | 0 | $0 |
| 2023-01 | 0 | $0 | 200 | $2,000 | 0 | $0 |
| 2022-06 | 0 | $0 | 0 | $0 | 11,160 | $49,996 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-03 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 6,345 | 20.07 | 127,318 |
| 2025-09-03 | Kaye Edward M. Md | Sale | 45,996 | 20.13 | 925,853 |
| 2025-09-02 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 14,922 | 20.14 | 300,499 |
| 2025-09-02 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Option Ex | 9,150 | 7.07 | 64,690 |
| 2025-09-02 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 5,501 | 19.87 | 109,326 |
| 2025-09-02 | Kaye Edward M. Md | Sale | 14,860 | 20.14 | 299,265 |
| 2025-08-29 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 850 | 20.00 | 17,000 |
| 2025-08-29 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Option Ex | 850 | 7.07 | 6,009 |
| 2025-08-29 | Kaye Edward M. Md | Sale | 1,029 | 20.00 | 20,580 |
| 2025-08-18 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 1,683 | 18.24 | 30,694 |
| 2025-08-18 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 2,805 | 18.24 | 51,157 |
| 2025-08-18 | Kaye Edward M. Md | Sale | 12,126 | 18.24 | 221,153 |
| 2025-08-14 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Option Ex | 6,000 | .00 | 0 |
| 2025-08-14 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 10,000 | .00 | 0 |
| 2025-08-14 | Kaye Edward M. Md | Option Ex | 26,250 | .00 | 0 |
| 2025-08-13 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 13,712 | 15.00 | 205,680 |
| 2025-08-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 4,504 | 12.82 | 57,723 |
| 2025-07-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 4,503 | 11.63 | 52,378 |
| 2025-06-30 | Levin Arthur A | Option Ex | 1,210 | .00 | 0 |
| 2025-06-03 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 6,471 | 10.03 | 64,891 |
| 2025-06-02 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 1,745 | 10.00 | 17,450 |
| 2025-05-02 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 22,790 | 10.03 | 228,538 |
| 2025-05-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 3,841 | 10.00 | 38,410 |
| 2025-03-31 | Levin Arthur A | Option Ex | 1,210 | .00 | 0 |
| 2025-03-19 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 1,945 | 8.27 | 16,085 |
| 2025-03-19 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 3,333 | 8.27 | 27,563 |
| 2025-03-19 | Kaye Edward M. Md | Sale | 8,907 | 8.27 | 73,660 |
| 2025-03-18 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 2,266 | 8.67 | 19,646 |
| 2025-03-18 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 3,884 | 8.67 | 33,674 |
| 2025-03-18 | Kaye Edward M. Md | Sale | 10,382 | 8.67 | 90,011 |
| 2025-03-15 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Option Ex | 13,475 | .00 | 0 |
| 2025-03-15 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 23,100 | .00 | 0 |
| 2025-03-15 | Kaye Edward M. Md (CEO) | Option Ex | 61,750 | .00 | 0 |
| 2024-12-09 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 13,666 | 13.34 | 182,304 |
| 2024-12-09 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 2,586 | 12.99 | 33,594 |
| 2024-12-09 | Kaye Edward M. Md (CEO) | Sale | 6,786 | 12.99 | 88,156 |
| 2024-12-06 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 9,696 | 12.78 | 123,895 |
| 2024-12-06 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 13,945 | 12.78 | 178,189 |
| 2024-12-06 | Kaye Edward M. Md (CEO) | Sale | 6,170 | 12.78 | 78,840 |
| 2024-12-03 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Option Ex | 6,000 | .00 | 0 |
| 2024-12-03 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 10,000 | .00 | 0 |
| 2024-12-03 | Kaye Edward M. Md (CEO) | Option Ex | 26,500 | .00 | 0 |
| 2024-12-02 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 10,000 | 12.07 | 120,700 |
| 2024-12-02 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 10,000 | .60 | 6,000 |
| 2024-12-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 48,792 | .00 | 0 |
| 2024-12-01 | Kaye Edward M. Md (CEO) | Option Ex | 21,591 | .00 | 0 |
| 2024-11-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 10,000 | 12.68 | 126,800 |
| 2024-11-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 10,000 | .60 | 6,000 |
| 2024-10-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 10,000 | 12.06 | 120,650 |
| 2024-10-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 10,000 | .60 | 6,000 |
| 2024-09-19 | Montrago Trustees Ltd (10% Owner) | Sale | 1,937,500 | 14.05 | 27,221,875 |
| 2024-09-03 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 10,000 | 15.16 | 151,630 |
| 2024-09-03 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 10,000 | .60 | 6,000 |
| 2024-08-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 10,000 | 14.58 | 145,840 |
| 2024-08-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 10,000 | .60 | 6,000 |
| 2024-07-02 | Nash Huw M. (Chief Business Officer) | Sale | 2,500 | 13.50 | 33,752 |
| 2024-07-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 10,000 | 13.75 | 137,460 |
| 2024-07-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 10,000 | .60 | 6,000 |
| 2024-06-03 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 10,000 | 15.50 | 154,960 |
| 2024-06-03 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 10,000 | .60 | 6,000 |
| 2024-04-17 | Montrago Trustees Ltd (10% Owner) | Sale | 3,600,000 | 11.60 | 41,760,000 |
| 2024-03-28 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 5,126 | 13.50 | 69,195 |
| 2024-03-19 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Sale | 2,349 | 6.10 | 14,326 |
| 2024-03-19 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 4,116 | 6.10 | 25,103 |
| 2024-03-19 | Nash Huw M. (COO & CBO) | Sale | 4,116 | 6.10 | 25,103 |
| 2024-03-19 | Kaye Edward M. Md (CEO) | Sale | 11,150 | 6.10 | 68,003 |
| 2024-03-19 | Tulipano Stephen J (CFO) | Sale | 4,116 | 6.10 | 25,103 |
| 2024-03-15 | Allan Jonathan (GENERAL COUNSEL & CORP SEC) | Option Ex | 7,475 | .00 | 0 |
| 2024-03-15 | Ticho Barry (CHIEF MEDICAL OFFICER) | Option Ex | 13,100 | .00 | 0 |
| 2024-03-15 | Nash Huw M. (COO & CBO) | Option Ex | 13,100 | .00 | 0 |
| 2024-03-15 | Kaye Edward M. Md (CEO) | Option Ex | 35,500 | .00 | 0 |
| 2024-03-15 | Tulipano Stephen J (CFO) | Option Ex | 13,100 | .00 | 0 |
| 2024-02-13 | Tzianabos Arthur | Option Ex | 31,739 | 2.19 | 69,508 |
| 2024-02-01 | Ticho Barry (CHIEF MEDICAL OFFICER) | Sale | 10,000 | 4.80 | 47,990 |
| 2024-01-02 | Ticho Barry (Chief Medical Officer) | Sale | 10,000 | 5.74 | 57,350 |
| 2023-07-03 | Ticho Barry (Chief Medical Officer) | Sale | 15,000 | 10.60 | 158,970 |
| 2023-06-21 | Allan Jonathan (General Counsel & Corp Sec) | Sale | 5,844 | 13.48 | 78,759 |
| 2023-06-01 | Ticho Barry (Chief Medical Officer) | Sale | 15,000 | 11.13 | 166,965 |
| 2023-05-04 | Ticho Barry (Chief Medical Officer) | Sale | 653 | 10.00 | 6,530 |
| 2023-05-03 | Ticho Barry (Chief Medical Officer) | Sale | 24,697 | 10.14 | 250,378 |
| 2023-05-02 | Ticho Barry (Chief Medical Officer) | Sale | 5,513 | 10.00 | 55,135 |
| 2023-05-01 | Ticho Barry (Chief Medical Officer) | Sale | 24,967 | 10.00 | 249,769 |
| 2023-03-27 | Kaye Edward M. Md (CEO) | Option Ex | 20,000 | .60 | 12,000 |
| 2023-02-06 | Ticho Barry (Chief Medical Officer) | Sale | 9,235 | 10.02 | 92,488 |
| 2023-02-03 | Ticho Barry (Chief Medical Officer) | Sale | 3,763 | 10.03 | 37,746 |
| 2023-02-02 | Ticho Barry (Chief Medical Officer) | Sale | 267 | 10.00 | 2,670 |
| 2023-02-01 | Ticho Barry (Chief Medical Officer) | Sale | 5,705 | 10.02 | 57,141 |
| 2023-01-31 | Ticho Barry (Chief Medical Officer) | Sale | 200 | 10.00 | 2,000 |
| 2022-06-02 | Tulipano Stephen J (CFO) | Option Ex | 11,160 | 4.48 | 49,996 |
| 2022-05-25 | Kaye Edward M. Md (CEO) | Option Ex | 15,000 | .60 | 9,000 |
| 2022-01-03 | Nash Huw M. (COO & CBO) | Sale | 3,800 | 23.31 | 88,593 |
| 2022-01-03 | Nash Huw M. (COO & CBO) | Option Ex | 3,800 | 2.19 | 8,322 |
| 2021-12-01 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 24.51 | 139,712 |
| 2021-12-01 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2021-11-03 | Nash Huw M. (COO & CBO) | Sale | 1,900 | 25.00 | 47,500 |
| 2021-11-03 | Nash Huw M. (COO & CBO) | Option Ex | 1,900 | 2.19 | 4,161 |
| 2021-11-01 | Nash Huw M. (COO & CBO) | Sale | 3,800 | 23.57 | 89,547 |
| 2021-11-01 | Nash Huw M. (COO & CBO) | Option Ex | 3,800 | 2.19 | 8,322 |
| 2021-10-01 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 24.83 | 141,508 |
| 2021-10-01 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2021-09-01 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 26.00 | 148,222 |
| 2021-09-01 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2021-08-02 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 28.87 | 164,553 |
| 2021-08-02 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2021-07-13 | Ticho Barry (Chief Medical Officer) | Sale | 43,166 | 33.12 | 1,429,571 |
| 2021-07-01 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 33.33 | 189,986 |
| 2021-07-01 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2021-06-01 | Nash Huw M. (COO & CBO) | Sale | 575 | 39.42 | 22,669 |
| 2021-06-01 | Nash Huw M. (COO & CBO) | Option Ex | 575 | 2.19 | 1,259 |
| 2021-03-02 | Liau Gene (EVP Research & Preclinical Dev) | Sale | 5,195 | 62.99 | 327,227 |
| 2021-03-02 | Liau Gene (EVP Research & Preclinical Dev) | Option Ex | 5,195 | .60 | 3,117 |
| 2021-03-01 | Levin Arthur A (Director) | Sale | 12,500 | 60.85 | 760,600 |
| 2021-03-01 | Levin Arthur A (Director) | Option Ex | 12,500 | .47 | 5,837 |
| 2021-02-23 | Tulipano Stephen J (CFO) | Sale | 5,000 | 58.60 | 292,990 |
| 2021-02-23 | Tulipano Stephen J (CFO) | Option Ex | 5,000 | 4.48 | 22,400 |
| 2021-02-22 | Tulipano Stephen J (CFO) | Sale | 25,000 | 59.32 | 1,483,000 |
| 2021-02-22 | Tulipano Stephen J (CFO) | Option Ex | 25,000 | 4.48 | 112,000 |
| 2021-02-19 | Tzianabos Arthur (Director) | Sale | 10,000 | 60.66 | 606,650 |
| 2021-02-19 | Tzianabos Arthur (Director) | Option Ex | 10,000 | 2.19 | 21,900 |
| 2021-01-06 | Nash Huw M. (COO & CBO) | Sale | 32 | 57.14 | 1,828 |
| 2021-01-04 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 59.26 | 337,770 |
| 2021-01-04 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2020-12-30 | Kaye Edward M. Md (CEO) | Option Ex | 10,000 | .60 | 6,000 |
| 2020-12-28 | Liau Gene (EVP Research & Preclinical Dev) | Sale | 149 | 58.73 | 8,750 |
| 2020-12-28 | Liau Gene (EVP Research & Preclinical Dev) | Option Ex | 8,000 | .60 | 4,800 |
| 2020-12-21 | Ticho Barry (Chief Medical Officer) | Sale | 1,365 | 57.92 | 79,067 |
| 2020-12-21 | Ticho Barry (Chief Medical Officer) | Option Ex | 1,365 | 2.19 | 2,989 |
| 2020-12-18 | Nash Huw M. (COO & CBO) | Sale | 8,015 | 60.00 | 480,900 |
| 2020-12-18 | Nash Huw M. (COO & CBO) | Option Ex | 8,015 | .60 | 4,809 |
| 2020-12-18 | Kaye Edward M. Md (CEO) | Sale | 5,194 | 60.00 | 311,640 |
| 2020-12-17 | Nash Huw M. (COO & CBO) | Sale | 41,985 | 60.00 | 2,519,100 |
| 2020-12-17 | Nash Huw M. (COO & CBO) | Option Ex | 41,985 | .60 | 25,191 |
| 2020-12-17 | Kaye Edward M. Md (CEO) | Sale | 19,806 | 60.00 | 1,188,360 |
| 2020-12-01 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 50.84 | 289,816 |
| 2020-12-01 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2020-11-27 | Kaye Edward M. Md (CEO) | Sale | 12,152 | 50.00 | 607,600 |
| 2020-11-25 | Kaye Edward M. Md (CEO) | Sale | 12,848 | 50.00 | 642,400 |
| 2020-11-24 | Atp Iii Gp, Ltd. (10% Owner) | Buy | 375,000 | 39.00 | 14,625,000 |
| 2020-11-24 | Harrison Seth Loring (Director) | Buy | 375,000 | 39.00 | 14,625,000 |
| 2020-11-23 | Tzianabos Arthur (Director) | Sale | 20,000 | 46.38 | 927,520 |
| 2020-11-23 | Tzianabos Arthur (Director) | Option Ex | 20,000 | 2.19 | 43,800 |
| 2020-11-10 | Nash Huw M. (COO & CBO) | Sale | 50,000 | 45.00 | 2,250,000 |
| 2020-11-10 | Nash Huw M. (COO & CBO) | Option Ex | 50,000 | 1.40 | 69,750 |
| 2020-11-04 | Tulipano Stephen J (CFO) | Sale | 33,268 | 41.14 | 1,368,578 |
| 2020-11-04 | Tulipano Stephen J (CFO) | Option Ex | 33,268 | 4.48 | 149,040 |
| 2020-11-03 | Tulipano Stephen J (CFO) | Sale | 1,732 | 39.84 | 68,997 |
| 2020-11-03 | Tulipano Stephen J (CFO) | Option Ex | 1,732 | 4.48 | 7,759 |
| 2020-11-02 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 37.29 | 212,547 |
| 2020-11-02 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2020-11-02 | Tulipano Stephen J (CFO) | Sale | 35,000 | 37.70 | 1,319,325 |
| 2020-11-02 | Tulipano Stephen J (CFO) | Option Ex | 35,000 | 4.48 | 156,800 |
| 2020-10-19 | Liau Gene (EVP Research & Preclinical Dev) | Sale | 32,000 | 38.03 | 1,216,992 |
| 2020-10-19 | Liau Gene (EVP Research & Preclinical Dev) | Option Ex | 32,000 | 1.40 | 44,640 |
| 2020-10-16 | Liau Gene (EVP Research & Preclinical Dev) | Sale | 5,851 | 40.00 | 234,040 |
| 2020-10-16 | Liau Gene (EVP Research & Preclinical Dev) | Option Ex | 5,851 | .60 | 3,510 |
| 2020-10-13 | Liau Gene (EVP Research & Preclinical Dev) | Sale | 1,649 | 40.00 | 65,960 |
| 2020-10-13 | Liau Gene (EVP Research & Preclinical Dev) | Option Ex | 1,649 | .60 | 989 |
| 2020-10-01 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 34.59 | 197,191 |
| 2020-10-01 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2020-09-09 | Nash Huw M. (COO & CBO) | Sale | 17,201 | 30.00 | 516,030 |
| 2020-09-09 | Nash Huw M. (COO & CBO) | Option Ex | 17,201 | 2.19 | 37,670 |
| 2020-09-08 | Nash Huw M. (COO & CBO) | Sale | 30,718 | 30.00 | 921,540 |
| 2020-09-08 | Nash Huw M. (COO & CBO) | Option Ex | 30,718 | 2.19 | 67,272 |
| 2020-09-01 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 28.16 | 160,494 |
| 2020-09-01 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2020-08-28 | Nash Huw M. (COO & CBO) | Sale | 2,081 | 30.00 | 62,430 |
| 2020-08-28 | Nash Huw M. (COO & CBO) | Option Ex | 2,081 | 2.19 | 4,557 |
| 2020-08-03 | Nash Huw M. (COO & CBO) | Sale | 5,700 | 24.73 | 140,943 |
| 2020-08-03 | Nash Huw M. (COO & CBO) | Option Ex | 5,700 | 2.19 | 12,483 |
| 2020-07-16 | Nash Huw M. (COO & CBO) | Sale | 1,900 | 25.06 | 47,614 |
| 2020-07-16 | Nash Huw M. (COO & CBO) | Option Ex | 1,900 | 2.19 | 4,161 |
| 2020-07-07 | Walker Robin A. (Chief Legal Officer, CCO & Sec) | Sale | 941 | 22.50 | 21,172 |
| 2020-07-07 | Nash Huw M. (COO & CBO) | Sale | 913 | 22.41 | 20,456 |
| 2020-07-01 | Nash Huw M. (COO & CBO) | Sale | 3,800 | 23.15 | 87,966 |
| 2020-07-01 | Nash Huw M. (COO & CBO) | Option Ex | 3,800 | 2.19 | 8,322 |
| 2020-06-01 | Ticho Barry (Chief Medical Officer) | Sale | 1,365 | 27.58 | 37,642 |
| 2020-06-01 | Ticho Barry (Chief Medical Officer) | Option Ex | 174,027 | 1.40 | 242,767 |
| 2020-06-01 | Nash Huw M. (COO & CBO) | Sale | 2,107 | 27.28 | 57,485 |
| 2020-06-01 | Nash Huw M. (COO & CBO) | Option Ex | 2,107 | 2.19 | 4,614 |
| 2020-06-01 | Liau Gene (EVP Research & Preclinical Dev) | Sale | 20,000 | 26.74 | 534,740 |
| 2020-06-01 | Liau Gene (EVP Research & Preclinical Dev) | Option Ex | 20,000 | 2.19 | 43,800 |
| 2020-05-22 | Liau Gene (EVP Research & Preclinical Dev) | Sale | 7,500 | 30.00 | 225,000 |
| 2020-05-22 | Liau Gene (EVP Research & Preclinical Dev) | Option Ex | 7,500 | .60 | 4,500 |
| 2020-03-31 | Liau Gene (EVP Research & Preclinical Dev) | Option Ex | 7,500 | .60 | 4,500 |
| 2020-03-02 | Nash Huw M. (COO & CBO) | Sale | 49,143 | 26.02 | 1,278,651 |
| 2020-03-02 | Nash Huw M. (COO & CBO) | Option Ex | 49,103 | 1.29 | 63,588 |
| 2019-12-20 | Liau Gene (EVP Research & Preclinical Dev) | Option Ex | 6,000 | .60 | 3,600 |
| 2019-12-16 | Kaye Edward M. Md (CEO) | Option Ex | 50,000 | .60 | 30,000 |
| 2019-11-08 | Wong Roderick | Sale | 16,434 | 28.70 | 471,639 |
| 2019-11-04 | Wong Roderick | Buy | 104,873 | 29.24 | 3,066,801 |
| 2019-11-01 | Wong Roderick | Buy | 8,598 | 28.61 | 245,954 |
| 2019-10-31 | Wong Roderick | Buy | 18,747 | 28.15 | 527,653 |
| 2019-10-30 | Wong Roderick | Buy | 41,438 | 28.79 | 1,193,000 |
| 2019-10-01 | Wong Roderick | Buy | 31,560 | 21.96 | 693,026 |
| 2019-06-21 | Atp Iii Gp, Ltd. | Buy | 1,388,889 | 18.00 | 25,000,002 |
| 2019-06-21 | Harrison Seth Loring | Buy | 1,388,889 | 18.00 | 25,000,002 |
| 2019-06-19 | Wong Roderick | Buy | 555,556 | 18.00 | 10,000,008 |
Insider trading activities including stock purchases, stock sales, and option exercises of STOK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Stoke Therapeutics, Inc. (symbol STOK, CIK number 1623526) see the Securities and Exchange Commission (SEC) website.